Hagler Mark Arnold bought NBP
April 24, 2026 · Form 4 insider transaction
Hagler Mark Arnold bought 230,000 shares of NovaBridge Biosciences at $2.51 per share, a transaction worth $577.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.; The reported securities are represented by 100,000 ADSs.; The price reported in Column 4 is a weighted average price. These ADSs were purchased in multiple transactions at prices ranging from $2.44 to $2.54, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.